Compare Badger Meter Inc (BMI) vs Johnson & Johnson (JNJ) Price & Performance

Badger Meter (BMI) trades at $134.77, down 1.22% amid bearish technical signals and mixed quarterly results. The stock shows strong profitability with 14.27% net margins and 18.48% ROE, though valuation appears elevated with a P/E of 31.78. Recent news highlights multiple class-action lawsuits filed against the company, creating investor uncertainty despite insider buying activity and institutional position increases.

BMI faces near-term headwinds from legal challenges and earnings misses, but maintains solid fundamentals and analyst consensus target of $155.20 suggests 15% upside potential. The key risk remains resolution of securities litigation, while the company's strong cash flow generation and market position in water technology provide long-term stability.

Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.

Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.